Skip to main content
logo
Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
24.97
-0.46 (-1.81%)
Sep 1, 2026, 11:48 AM EDT - Market open

Dyne Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,6633,2212,398816604606
Market Cap Growth
142.98%34.33%193.72%35.12%-0.32%-36.50%
Enterprise Value
3,9982,5491,699687387233
Last Close Price
25.4319.5623.5613.3011.5911.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.003.313.818.942.391.65
P/TBV Ratio
6.603.313.818.942.391.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.330.170.040.300.120.09
Net Debt / Equity Ratio
-0.95-0.97-0.98-1.05-0.89-0.93
Net Debt / EBITDA Ratio
1.242.021.810.401.332.31
Net Debt / FCF Ratio
1.332.222.100.511.442.79
Quick Ratio
11.5221.9415.202.419.1213.11
Current Ratio
12.0222.2515.602.539.4613.31
Return on Equity (ROE)
-81.56%-55.71%-88.03%-137.31%-54.18%-42.02%
Return on Assets (ROA)
-38.95%-31.16%-50.20%-64.21%-29.20%-24.07%
Return on Capital Employed (ROCE)
-58.60%-41.20%-53.00%-212.40%-61.40%-37.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.21%-13.86%-13.24%-28.90%-27.82%-24.63%
FCF Yield
-10.77%-13.16%-12.29%-23.14%-25.94%-20.33%
Buyback Yield / Dilution
-45.37%-36.43%-57.74%-14.83%-2.13%-253.54%
SEC Filings: 10-K · 10-Q